Blood-based epigenetic signatures enable early risk assessment in prediabetes
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research has found that blood-based epigenetic signatures can be used for early risk assessment in prediabetes. This discovery may allow for earlier identification of those at risk. The use of epigenetic signatures in blood is being explored as a potential tool for assessing prediabetes risk.